Bharat Biotech cuts vaccine price for States to ₹400/dose
The Hindu
This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
Bharat Biotech on Thursday announced a cut in price of its it plans to sell to the States to . This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
Telangana Legislature's winter session on December 9, 2024 to focus on new legislation, rectifying past Acts, and addressing social indicators and financial issues.
Central government officials raise concerns over vague replies on vacancies and recruitments in Central ministries, highlighting data discrepancies.
Supreme Court directs five states to provide facts on illegal sand mining activities, emphasizing the need for control.
Vazhndhu Kattuvom scheme in Tiruchi district empowers women entrepreneurs through vocational training and e-commerce platforms for business growth.
Chennai airport passengers face challenges with defective trolley wheels, but improvements are underway by AAI officials.
J&K leaders oppose new railway lines cutting through agriculture and horticulture land in south Kashmir, citing ecological and livelihood concerns.
Preliminary study at IIT Madras' Vana Vani School raises concerns over unauthorized clinical trials on students.
Shortage of clinical psychologists in India due to discontinuation of MPhil program raises concerns about education and accreditation standards.
Producers of Tamil movie Amaran apologize for displaying student's number, leading to legal action and removal of scene.
Telangana Chief Minister initiates recruitment of transgender Traffic Assistants in Hyderabad Police for inclusivity and representation.
Forest Minister K. Ponmudy launches 60 mobile medical units for Cyclone Fengal relief in Villupuram district.